Pitiriasis Alba

01Pathophysiology

Pityriasis alba is best understood as a low-grade, subclinical eczematous process that disrupts normal melanin production and transfer. The condition sits on the mild end of the atopic dermatitis spectrum, and many patients will have a personal or family history of atopy.

The underlying mechanism begins with mild inflammation in the epidermis, which is often so subtle that the erythematous phase goes unnoticed, particularly in lighter skin tones. This inflammation damages melanocytes and, more importantly, impairs the transfer of melanosomes from melanocytes to surrounding keratinocytes. The result is post-inflammatory hypopigmentation rather than true melanocyte destruction.

The reason you see fine, powdery scale is that the stratum corneum undergoes low-grade disruption from this subclinical dermatitis. The abnormal keratinization scatters light differently across the affected patch, which further contributes to the pale appearance. Sun exposure does not cause the condition but makes it more apparent: surrounding normal skin tans while the affected areas, with their reduced melanin output, cannot keep pace. This is why parents often notice the patches more during summer months.

Critically, the melanocytes themselves are still present and functional in pityriasis alba. They are simply underperforming due to the inflammatory milieu. This is the fundamental distinction from vitiligo, where melanocytes are destroyed by autoimmune mechanisms, leading to complete depigmentation.

02Clinical Manifestation & Classification

Pityriasis alba does not have a formal staging system, but it progresses through recognizable clinical phases:

Key clinical features across all variants:

• Lesion size typically ranges from 0.5 to 5 cm in diameter

• Borders are ill-defined and irregular, a hallmark feature that distinguishes it from tinea versicolor and vitiligo

• The scale is fine, dry, and described as "powdery" or "dust-like"

• Lesions are asymptomatic or mildly pruritic; severe itch should prompt reconsideration of the diagnosis

03Diagnostic Workup

Pityriasis alba is fundamentally a clinical diagnosis. The classic triad of a young patient with atopic history, hypopigmented facial patches, and fine scale is sufficient to make the diagnosis without any laboratory workup.

The Wood lamp becomes important when the examiner needs to differentiate pityriasis alba from vitiligo. Under Wood lamp, pityriasis alba shows dull, off-white enhancement because melanin is reduced but not absent. Vitiligo, in contrast, shows bright, porcelain-white fluorescence with sharply demarcated borders because melanocytes are completely destroyed. This is a commonly tested distinction.

A KOH scraping should be considered when the differential includes tinea versicolor or tinea faciei. In pityriasis alba, the KOH prep will be negative. Tinea versicolor classically shows the "spaghetti and meatballs" pattern of short hyphae and round spores.

Biopsy is almost never needed. Reserve it for cases where the presentation is atypical (e.g., an adult with progressive depigmentation, lesions unresponsive to treatment, or concern for early mycosis fungoides in the form of hypopigmented patches). On histology, you would see mild chronic dermatitis with reduced melanin granules in the basal layer but intact melanocytes, confirming the post-inflammatory nature of the hypopigmentation.

04Management & Treatment

The cornerstone of management is reassurance. Parents are frequently worried about vitiligo or a fungal infection, and a clear explanation that this is a benign condition associated with mild eczema, with full repigmentation expected over months to years, addresses the primary concern.

Emollients (e.g., petroleum jelly, ceramide-based moisturizers) should be applied liberally and frequently. They restore the epidermal barrier, reduce transepidermal water loss, and help normalize keratinization, which diminishes the visible scale and improves the cosmetic appearance.

When the patches show active inflammation (erythema, more pronounced scaling), a low-potency topical corticosteroid such as hydrocortisone 1% cream can be applied once to twice daily for short courses of 2 to 4 weeks. Because the face is the most common site, prolonged corticosteroid use carries risks of skin thinning, telangiectasia, and perioral dermatitis. This is why topical calcineurin inhibitors (tacrolimus 0.03% ointment or pimecrolimus 1% cream) are preferred as steroid-sparing agents for facial application. They can be used twice daily without the atrophic side effects of steroids. Note: calcineurin inhibitors carry an FDA black box warning regarding theoretical lymphoma risk, though clinical data have not confirmed this association. They are approved for use in children aged 2 years and older.

Sun protection is consistently underemphasized but is an important adjunctive measure. The lesions themselves do not worsen with sun exposure, but surrounding skin will darken, making the contrast more obvious. Regular sunscreen use helps minimize this visual discrepancy while the patches slowly repigment.

For refractory or cosmetically distressing cases, narrow-band UVB phototherapy can be considered. It stimulates melanocyte activity and promotes repigmentation. This is rarely needed but is the next step when conservative measures fail over many months.

05Differential Diagnosis & Distractors

06Traps & High-Yield Pearls

The most common way students get this topic wrong is by confusing pityriasis alba with vitiligo. Both present with lighter patches in children, but the question stem will contain deliberate clues to steer you toward the correct answer. Look for the words "ill-defined," "fine scale," and "atopic history" as signals pointing toward pityriasis alba. Vitiligo vignettes will emphasize "well-demarcated," "depigmented" (not hypopigmented), and often mention autoimmune comorbidities such as thyroid disease or type 1 diabetes.

A second common trap involves tinea versicolor. Students see "hypopigmented and scaly" and reach for an antifungal. The key discriminator is location: tinea versicolor overwhelmingly affects the trunk, while pityriasis alba favors the face. Additionally, a KOH prep resolves any ambiguity.

Another pitfall is over-investigating or over-treating. When a vignette presents a classic case and asks for the "next best step," the answer is reassurance and emollients, not a biopsy, not a KOH, and not a topical steroid. Students who have been trained to "always do something" will pick an unnecessary workup. The exam tests whether you can recognize a benign, self-limiting condition and manage it conservatively.

Finally, be alert for the rare but testable scenario of hypopigmented mycosis fungoides masquerading as pityriasis alba. If the vignette describes hypopigmented patches in a young person but the lesions are in non-sun-exposed, "bathing trunk" distribution, are refractory to standard treatment, or the patient is an adolescent or young adult with progressively worsening patches, the answer shifts to skin biopsy to rule out cutaneous T-cell lymphoma. The core competency being tested here is your ability to identify the atypical features that break the pattern and warrant further investigation.